Olisferrol® is a blood supplement and was discovered by Dr. Nzedegwu Robert Olisa, III. PhD in April 2003. Biochemically, it consists entirely of an enzyme (vitamin)-based CXCR-antagonist, thus functions as a biostatic-antibiotic against ALL opportunistic pathogens dependent on CXCR cell chemokine r...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2009 (17 years)
Employees by Department
- The Rest (1)
- Total (1)
Key Decision Makers
Financials
LOW
spending power
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has OLISFERROL®(BRAUNMYCIN) been operating for?
- Where is OLISFERROL®(BRAUNMYCIN)'s headquarter?
- What OLISFERROL®(BRAUNMYCIN)'s spending power?
- Does OLISFERROL®(BRAUNMYCIN) have a presence in the domain it operates in?

